The FHI Clinical project team has partnered with companies to conduct clinical trials as well as epidemiological and observational studies for tuberculosis in 30 countries worldwide.
The FHI Clinical project team has partnered with companies to conduct clinical trials as well as behavioral and observational studies for HIV in 24 countries worldwide.
For nearly 20 years, the FHI Clinical project team has partnered with companies developing and deploying vaccines, treatments and preventive devices for malaria in 38 countries worldwide.
FHI Clinical has long-standing relationships, a local team and broad expertise in sub-Saharan Africa. We're ready to help you confidently expand your research across the region, finding the best-fit countries and populations for your target indication and study type.
Vaccines are critical to the eradication of infectious diseases worldwide. To achieve the FHI Clinical vision of a world where advances in vaccines help all people live longer, healthier lives, we’ve spent years honing our processes to respond to the urgency and complexity of vaccine trials, developing our global network of research-ready investigators and sites, and partnering with leading public and private medical research organizations, pharmaceutical and biotechnology companies, academic institutions, governments and non-governmental organizations.
To achieve our vision of a world where advances in vaccines help all people live longer, healthier lives, we’ve honed our processes to respond to the urgency and complexity of vaccine trials, developed our global network of investigators and sites, and partnered with organizations across public, private, academic and government sectors.
Our broad expertise, end-to-end services and ability to begin immediate collaboration with government, commercial and academic partners in more than 60 countries make us uniquely positioned to support the COVID-19 response. We address emerging pandemics, epidemics and outbreaks with expertise that supports health and research efforts globally. We are experienced in addressing the complex aspects of infectious diseases — from infection prevention and control to clinical research on diagnostics, vaccines and treatment.
FHI Clinical goes where our expertise is needed. Whether it requires working from a state-of-the-art facility or in a low-tech, rural setting, we provide services tailored to meet your study needs, from protocol design and site assessments to trial planning, implementation and management.
In this webinar, our panel of Africa-based researchers discuss the strong clinical research foundation, the community-centered approach and increasing regulatory harmonization in Africa. Watch to learn about the continent’s population diversity, expanding therapeutic area expertise and long-standing stakeholder engagement.
In this plenary discussion, experts in infectious diseases discuss how real-world epidemiology data, site capacity data and biosurveillance methodology could help identify TB-prevalent populations during protocol design, helping to ensure an adequate sample for TB vaccine development.